。AI-Copilot Platform。Advanced Medical Device Commercialization 。AI-Copilot Platform。Advanced Medical Device Commercialization 。AI-Copilot Platform。Advanced Medical Device Commercialization

Stop Drowning in Documentation
Focus on Building Better Medical Devices

Powered by our proprietary AI-Copilot platform, we accelerate the journey from product concept to regulatory- and CDMO-ready development — from months to just one day

1 day

From product concept to CDMO ready documentation

10 mins

ISO compliance risk analysis framework generation

80 %

Blind test comparison of FDA submission document accuracy

$30-40K

Estimated initial development cost savings (USD)

01 — About Union Medical

Your Strategic Partner for Accelerating MedTech Commercialization

Union Medical goes beyond traditional regulatory consulting. We are a forward-thinking strategic partner helping medical device innovators navigate the complexities of product development and commercialization.

Our mission is to bridge the critical information gap between innovators and CDMOs during the early stages of development — helping teams cross the first “Valley of Death” between product concept and scalable manufacturing.

By combining advanced software technology with deep industry expertise, we provide a streamlined, high-fidelity roadmap for product development, regulatory readiness, manufacturing, and capital planning.

UNIONMEDICAL

Partners

AI × Regulatory × Manufacturing × IP × Legal × Capital

One Integrated Ecosystem for MedTech Commercialization

Based in Taiwan and connected to markets across Japan and Southeast Asia, Union Medical integrates AI-powered standardized workflows with a multidisciplinary professional network to build a comprehensive ecosystem for global MedTech commercialization.

The Core

AI-Powered Early-Stage Development

(Day-One Readiness)

  • AI-Copilot|Generated in 10 Minutes
  • Risk Analysis Framework | CDMO-ready | pre-QMS

Global Regulatory Strategy

  • TFDA | FDA 510(k) | Japan PMDA
  • ISO 13485 QMS Implementation & Guidance

Capital & Resource Ecosystem

  • Business Model Planning | Government Funding Programs
  •  Investment Structuring | Global Supply Chain

Ecosystem Integration

Front End: IP & Technology Barriers

Mocheng Intellectual Property

  • Day-One Patent Search & Strategy
  • Freedom-to-Operate (FTO) Assessment
  • Global Patent Strategy
  • Enhance Valuation & Investment Appeal

Patents Are More Than Protection — They Drive Valuation

Midstream: Product Development & Mass Production

ENDOSEMIO Medical Technology

  • CDMO Development & System Integration
  • Standardized Documentation for Pilot Production & Validation
  • 80%+ Accuracy in DfM Review
  • “Ready for Submission” Quality Output
  • Transform Advanced Product Concepts into Production-Ready Systems

United Precision

  • Precision Machining & Component Development
  • High-Complexity Mold Development
  • Micro-Optics & Precision Sensor Module Development
  • Design for Manufacturability (DFM)
  • Functional Prototyping to Mass Production Validation

Back End: Compliance & Capital Protection

Mogeng Law Firm

  • Investor Agreement (Term Sheet) Review
  • Supply Chain NDAs & Development Agreements
  • Startup & Equity Structure Protection
  • Legal Support for Cross-Border Regulatory & Commercial Negotiations

Protecting Fundraising, Expansion & Technology Transfer

Strategic Partner: Clinical & Market Access

NeoPedTech

  • Sales Distribution: Neonatology, Pain Medicine & ENT
  • IRB & Clinical Collaboration

Future Direction & Vision

Three-Pillar Synergy: R&D × Regulatory × Capital

Bridging Global MedTech Innovators with Leading CDMOs

Rooted in Taiwan, Expanding into Japan and Southeast Asia (Singapore & the Philippines)

Standardizing Workflows with AI to Reduce Costs and Risks, Accelerate Commercialization

80+

·DHF Information Accuracy
·High-Fidelity Documentation

— Core Advantages

Ecosystem Value Creation

Bridge Early-Stage Information Gaps

Cross the First “Valley of Death”

Reduce Development Costs & Risks

Accelerate Regulatory Approval, Manufacturing & Capital Access

02 — SERVICE INTRODUCTION

One Integrated Ecosystem for MedTech Commercialization

Based in Taiwan and connecting to markets across Japan and Southeast Asia, Union Medical integrates AI-powered standardized workflows to build a comprehensive ecosystem for global MedTech commercialization.

Bridging the First Valley of Death

Medical device innovators bring clinical insights and breakthrough technologies, while CDMOs bring engineering and manufacturing expertise.

Yet a fundamental disconnect often exists between the two.

This information gap during early-stage development can delay clinical evidence generation, create costly redesign cycles, and significantly increase overall development costs.

Through our three core services, Union Medical bridges this gap by delivering clear, actionable, and CDMO-ready documentation — enabling faster, more efficient, and higher-quality product development.

Three Core Services

AI Product Concepts and Design

Three inputs, one hour to generate CDMO-ready and pre-QMS design files.


Learn about our services  →

Global regulations and evidence collection

TFDA, FDA, PMDA certification pathway planning and ISO 13485 establishment.


Learn about our services  →

New venture capital and government plans

Government subsidy coordination, business model analysis and corporate structure, and capital planning.

Learn about our services  →

01

 AI Product Concept & Design

AI-Powered Product Concept & Design

Turning Complexity into Clarity

Day-One Ready: AI-Enabled Design Inputs and Early-Stage Risk

Assessment

Medical device startups often underestimate the complexity of design documentation — largely because their teams have limited experience creating and applying these documents throughout the development process.

With our AI-Copilot platform, all you need are three core inputs :

1.Problem

2.Solution

3.Expected Outcome

From there, our platform transforms your product concept into structured development documentation.

Critical Compliance Documents Generated Within One Hour


Forget spending months searching for templates, structuring documents, and repeatedly rewriting specifications.


Within just one hour, our AI-Copilot can generate CDMO-ready, pre-QMS design documentation, including:


Design Requirements

Design Specifications

Design Verification Documents

Risk Management Plan

These structured outputs give your engineering, manufacturing, and regulatory teams a shared foundation from day one.

ISO-Aligned Risk Analysis in Just 10 Minutes


For advanced medical devices integrating miniature optics, electronics, software, and hardware — including disposable endoscopes, smart pressure-sensing video laryngoscopes, and handheld pupillometers — our system can generate structured risk analysis frameworks and diagrams aligned with international standards such as ISO 14708-1 in as little as 10 minutes.


Estimated development cost savings (USD)

$30,000-40,000

02

Global regulatory strategy & market approval

From Development to Submission — Seamlessly


Submission-ready documentation built on high-fidelity data

Successful medical device commercialization depends on seamless execution across multiple disciplines.


Because our AI platform establishes structured, high-accuracy Design History File (DHF) documentation early in the development process, these high-quality datasets can be efficiently transformed into the formats required by regulatory authorities around the world.


The result is a more streamlined submission process with fewer rounds of clarification and significantly reduced regulatory review cycles.


Your pathway to global markets

We specialize in developing optimized regulatory pathways for innovative and advanced medical devices.

Our services include:

  • Taiwan TFDA registration and preclinical testing support
  • U.S. FDA 510(k) / PMA regulatory strategy
  • Japan PMDA market-entry and registration strategy
  • ISO 13485 Quality Management System implementation and training, including compliant design and manufacturing Change Control processes

We are more than a regulatory consulting firm — we help turn medical innovation into a commercially viable business.


You bring the product vision and business strategy. We help translate complex technology into a compelling value proposition that investors, government reviewers, and strategic partners can clearly understand.


Our expertise is particularly valuable for business models that combine capital equipment with recurring disposable consumables, helping companies build stronger financial models, market strategies, and long-term revenue plans.

Strategic support beyond product development

Connecting Startups with Funding and Global Resources

Government Funding Programs

We support applications for government-funded R&D programs, from proposal development and business model refinement to overall application strategy — helping increase the competitiveness of each submission.

International Collaboration Programs

We identify international and bilateral R&D funding opportunities and help companies connect with overseas healthcare supply chains, strategic partners, and funding resources.

Corporate & Capital Planning

From company incorporation and name registration to capital structure planning and corporate banking setup, we provide strategic support for building a solid foundation for growth and international expansion.

03

Startup Funding & Government Programs

From Innovation to Commercialization: Funding, Strategy and Resources

Proven Results & Case Studies

Validated by MedTech Industry Leaders

Our AI-Copilot platform has supported medical device companies ranging from Seed-stage startups to Series D enterprises, helping accelerate product development without compromising quality.


By standardizing critical development data from the earliest stages, we help teams align product development, engineering, regulatory, manufacturing, and commercialization within one connected ecosystem.

EndoSemio

EndoSemio conducted a blind comparison between documentation generated by our AI-Copilot platform and the final Design History File (DHF) submitted to the U.S. FDA.

01. Design Requirements & Specifications

The AI-generated documents achieved over 80% information accuracy, demonstrating strong alignment with the final FDA submission and requiring only minor refinement and clarification.

02. Design Verification Outputs

The generated documentation demonstrated a highly complete structure and was considered nearly “Ready for Submission,” requiring only a final verification review.

Whether you are a Series A company developing a 510(k) non-invasive medical device or a Series D company navigating a highly complex PMA implantable device, our standardized data framework helps align your entire development ecosystem — from concept to commercialization.

03 - Contact Us

Contact Us

聯合生物科技顧問股份有限公司

“Integrating with the global industrial trend and overall partnership”